FDA approves new ALS drug tested in clinical trial at UF
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
Posts tagged as
Lou Gehrig’s Disease
MBI Rising Stars: Ariel Walker
Ariel Walker is the latest MBI Rising Star, a video series highlighting up-and-coming neuroscience researchers at UF.
Researchers report experimental drug may prolong survival in ALS patients
Trial drug combination shows potential to prolong survival of ALS patients by more than six months.
New trial drug combination shows promise for slowing progression of ALS
UF was the No. 2 enroller of patients for multisite ALS trial.
New preclinical study shows antibody therapy could offer treatment path for genetic form of ALS
Novel type of immunotherapy used in mouse-model study shows promise for ALS treatment.